Gene expression profiling of Non-small cell lung cancer
- Sunil Singhal(corresponding author),
- ,
- Suresh Ramalingam,
- Shi Yong Sun
- Emory University
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Functional genomics has emerged over the past 10 years as a novel technology to study genetic alterations. Gene expression arrays are one genomic technique employed to discover changes in the DNA expression that occur in neoplastic transformation. Microarrays have been applied to investigating lung cancer. Specific applications include discovering novel genetic changes that occur in lung tumors. Microarrays can also be applied to improve diagnosis, staging and discover prognostic markers. The eventual goal of this technology is to discover new markers for therapy and to customize therapy based on an individual tumor genetic composition. In this review, we present the current state of gene expression array technology in its application to lung cancer.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 313-324 (12 pages)Journal (Volume, Issue Number)
Lung Cancer (Volume 60, Issue 3)Publication milestones
- Published - 06/2008
Publication status
Published - 06/2008
ISSN
0169-5002Publication IDs
- Scopus: 44449164317
- PubMed: 18440087
Publication metrics
Metrics
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
64
Citation count
53
Funding Details
This work was supported by funding from the Emory Center for Respiratory Health and Emory-GT Center for Cancer Nanotechnology Excellence. The authors would like to thank Dr. Steven M. Albelda and Dr. Charles Powell for their valuable input into preparation of this manuscript
FundersFunding number
Emory-GT Center for Cancer Nanotechnology Excellence
-NCI
U54CA119338
